Infection of human marrow stroma by human immunodeficiency virus-1 (HIV- 1) is both required and sufficient for HIV-1-lnduced hematopoietic suppression in vitro: Demonstration by gene modification of primary human stroma

Blood

Volumn 90, Issue 5, 1997, Pages 1787-1798

  Bahner, Ingrid ^a   Kearns, Karen ^a   Coutinho, Sunita ^a   Leonard, Earl H ^a   Kohn, Donald B ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHEMICAL MODIFICATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEROCONVERSION; STEM CELL; STROMA CELL; VIRUS INDUCTION; VIRUS REPLICATION;

EID: 0030884458     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.5.1787     Document Type: Article

References (60)

1. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183, 1993
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-I infection, Nature 373:123, 1995
3. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117, 1995
4. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, Wexler LH, Gress RE: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143, 1995
5. Scadden DT, Zon LI, Groopman JE: Pathophysiology and management of HIV-1-associated hematologic disorders. Blood 74:1455, 1989
6. Davis BR, Zauli G: Effect of human immunodeficiency virus infection on haematopoiesis. Baillieres Clin Haematol 8:113, 1995
7. Davis BR, Young NS: Suppression of hematopoiesis by viruses, in Anagnostou A, Dainiak N, Najman A (eds): Negative Regulators of Hematopoiesis. Annals of the New York Academy of Sciences, vol 628. New York, NY, The New York Academy of Sciences, 1991, p 282
8. Donahue RE, Johnson MM, Zon LI, Clark SC, Groopman JE: Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature 326:200, 1987
9. Stella CC, Ganser A, Hoelzer D: Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest 80:286, 1987
10. Ganser A, Ottmann OG, von Briesen H, Volkers B, Rubsamen-Waigmann, Hoelzer D: Changes in the haematopoietic progenitor cell compartment in the acquired immunodeficiency syndrome. Res Virol 141:185, 1990
11. Davis BR, Schwartz DH, Marx JC, Johnson CE, Berry JM, Lyding J, Merrigan TC, Zander A: Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 65:1985, 1991
12. Zauli G, Re MC, Visani G, Furlini G, Mazza P, Vignoli M, La Placa M: Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis 166:710, 1992
13. + hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus type 1. Blood 84:1896, 1994
14. Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation of haemopoietic cells in vitro. J Cell Physiol 91:335, 1977
15. Deryugina EI, Muller-Sieburg CE: Stromal cells in long-term cultures: Keys to the elucidation of hematopoietic development? Crit Rev Immunol 13:115, 1993
16. Gordon MY, Riley GP, Watt SM, Greaves MF: Compartmentalization of a hematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326:403, 1987
17. Taichman RS, Emerson SG: Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 179:1677, 1994
18. Schwartz GN, Kessler SW, Rothwell SW, Burrell LM, Reid TJ, Meltzer MS, Wright DG: Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. Exp Hematol 22:1288, 1994
19. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986
20. Collins LS, Dorshkind K: A stromal cell line from myeloid long term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol 138:1082, 1987
21. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980, 1989
22. Heaphy S, Finch JT, Gait MJ, Karn J, Singh M: Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich bubble located within the rev-responsive region of viral mRNAs. Proc Natl Acad Sci USA 88:7366, 1991
23. Bahner I, Kearns K, Hao QL, Smogorzewska M, Kohn DB: Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits HIV-1 replication in the myelomonocytic cells produced in long-term culture. J Virol 70:4352, 1996
24. Morgan RA, Cornetta K, Anderson WF: Applications of the polymerase chain reaction in retroviral mediated gene transfer and the analysis of gene marked human TIL cells. Hum Gene Ther 1:135, 1990
25. Fleiss JL: Sampling method 1: Naturalistic or cross sectional studies, and Sampling method 2: Prospective and retrospective studies, in Bradley RA, Hunter JS, Kendall DG, Watson GS (eds): Statistical Methods for Rates and Proportions, chapter 5 (ed 2). New York, NY, Wiley, 1981, p 71, 85
26. Trono D, Baltimore D: A human cell factor is essential for HIV-1 Rev action. EMBO J 9:4155, 1990
27. Winslow BJ, Trono D: The blocks to human immunodeficiency virus type 1 Tat and Rev functions in mouse cell lines are independent. J Virol 67:2349, 1993
28. Lunardi-Iskandar Y, Georgoulias V, Bertoli AM, Augery-Bourget Y, Ammar A, Vittecoq D, Rosenbaum W, Meyer P, Jasmin C: Impaired in vitro proliferation of hematopoietic precursors in HIV-1-infected subjects. Leuk Res 13:573, 1989
29. Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M: Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects. Exp Hematol 18:426, 1990
30. Stanley SK, Kessler SW, Justement JS, Schnittman SM, Greenhouse JJ, Brown CC, Musongela L, Musey K, Kapita B, Fauci AS: CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 149:689, 1992
31. Zauli G, Re MC, Davis B, Sen L, Visani G, Gugliotta L, Furlini G, La Placa M: Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 sero-positive thrombocytopenic individuals. Blood 79:2680, 1992
32. DeLuca A, Teofili L, Antinori A, Iovino MS, Mencarini P, Visconti E, Tamburrini E, Leone G, Ortona L: Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol 85:20, 1993
33. Geissler RG, Ottmann OG, Kleiner K, Mentzel U, Bickelhaupt A, Hoelzer D, Ganser A: Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. Res Virol 144:69, 1993
34. Stutte HJ, Muller H, Falk S, Schmidts HL: Pathophysiological mechanisms of HIV-induced defects in haematopoiesis: Pathology of the bone marrow. Res Virol 141:195, 1990
35. Molina JM, Scadden DT, Sakaguchi M, Fuller B, Woon A, Groopman JE: Lack of evidence for infection of or effect on growth of haematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood 76:2476, 1990
36. Louache F, Henri A, Bettaieb A, Oksenhendler E, Raguin G, Tulliezz M, Vainchenker W: Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 80:2991, 1992
37. Kearns K, Bahner I, Bauer G, Wei SF, Valdez P, Wheeler S, Woods L, Miller R, Casciato D, Galpin J, Church J, Kohn DB: Suitability of bone marrow from HIV-1-infected donors for retroviral-mediated gene transfer. Human Gene Ther 8:310, 1997
38. + hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood 76:1281, 1990
39. + progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 86:1749, 1995
40. Folks TM, Kessler SW, Orenstein JM, Justement JS, Jaffe ES, Fauci AS: Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 242:919, 1988
41. Kitano K, Abboud CN, Ryan DH, Quan SG, Baldwin GC, Golde DW: Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type I infection in bone marrow stem cells. Blood 77:1699, 1991
42. + cells to human immunodeficiency virus type 1 does not influence their expansion and proliferation of hematopoietic progenitors in vitro. Blood 88:130, 196
43. Steinberg HN, Crumpacker CS, Chatis PA: In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus. J Virol 65:1765, 1991
44. Zauli G, Re MC, Furlini G, Giovannini M, La Placa M: Evidence for an HIV-1 mediated suppression of in vitro growth of enriched (CD34+) hematopoietic progenitors. J Acquir Immune Defic Syndr 4:1251, 1991
45. Cen D, Zauli G, Szarnicki R, Davis BR: Effect of different human immunodeficiency virus type-1 (HIV-1) isolates on long-term bone marrow haemopoiesis. Br J Haematol 85:596, 1993
46. Leiderman IZ, Greenberg ML, Adelsberg BR, Siegal FP: A glycoprotein inhibitor of in vitro granulopoiesis associated with AIDS. Blood 70:1267, 1987
47. Sugiura K, Oyaizu N, Pahwaa R, Kalyanaraman VS, Pahwa S: Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Blood 80:1463, 1992
48. Wickramasinghe SN, Beatty C, Shiels S, Tomlinson DR, Harris JW: Ultrastructure of the bone marrow in HIV infection: Evidence of dyshaemopoiesis and stromal cell damage. Clin Lab Haematol 14:213, 1992
49. Canque B, Marandin A, Rosenzwajg M, Louache F, Vainchenker W, Gluckman JC: Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV). Virology 208:779, 1995
50. Marandin A, Canque B, Coulombel L, Gluckman JC, Vainchenker W, Louache F: In vitro infection of bone marrow-adherent cells by human immunodeficiency virus type 1 (HIV-1) does not alter their ability to support hematopoiesis. Virology 213:245, 1995
51. Gill V, Shattock RJ, Freeman AR, Robinson G, Griffin GE, Gordon-Smith EC, Gibson FM: Macrophages are the major target for HIV infection in long-term marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV-1. Br J Haematol 93:30, 1996
52. Scadden DT, Zeira M, Woon A, Wang Z, Schieve L, Ikeuchi K, Lim B, Groopman JE: Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 76:317, 1990
53. Steinberg HN, Anderson J, Crumpacker CS, Chatis PA: HIV infection of the BS-1 human stroma cell line: Effect on murine hematopoiesis. Virology 193:524, 1993
54. Moses AV, Williams S, Heneveld ML, Strussenberg J, Rarick M, Loveless M, Bagby G, Nelson JA: Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 87:919, 1996
55. Schwartz GN, Kessler SW, Szabo JM, Burrell LM, Francis ML: Negative regulators may mediate some of the inhibitory effects of HIV-1 infected stromal cell layers on erythropoiesis and myelopoiesis in human bone marrow long term cultures. J Leukoc Biol 57:948, 1995
56. Zauli G, Davis BR, Re MC. Visani G, Furlini G, La Placa M: Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036, 1992
57. Scadden DT, Wang A, Zsebo KM, Groopman JE: In vitro effects of stern cell factor or interleukin-3 on myelosuppresion associated with AIDS. AIDS 8:193, 1994
58. Keating A, Singer JW, Killen PD, Striker GE, Salo AC, Sanders J, Thomas ED, Thorning D, Fialkow PJ: Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature 298:280, 1982
59. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B: Host origin of marrow stromal cells following bone marrow transplantation. Nature 328:429, 1987
60. Przepiorka D, Torok-Storb B, Simmons PJ: The origin of bone marrow stroma after transplantation: Implications for graft failure, in Testa NG, Gale RP (eds): Hematopoiesis Hematology, vol 8. New York, NY, Dekker, 1988